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Background: Coumarins are a major group of plant secondary metabolites that serves as defense compounds
against pathogens. Although coumarins can be obtained from diverse plant sources, the use of microorganisms to
synthesize them could be an alternative way to supply building blocks for the synthesis of diverse coumarin derivatives.
Results: Constructs harboring two genes, F6′H (encoding feruloyl CoA 6′ hydroxylase) and 4CL (encoding 4-coumarate
CoA:ligase), were manipulated to increase the productivity of coumarins. Escherichia coli expressing the two genes was
cultured in medium supplemented with hydroxycinnamic acids (HCs) including p-coumaric acid, caffeic acid, and
ferulic acid, resulting in the synthesis of the corresponding coumarins, umbelliferone, esculetin, and scopoletin.
Cell concentration and initial substrate feeding concentration were optimized. In addition, umbelliferone, and
esculetin were synthesized from glucose by using a ybgC deletion mutant and co-expressing tyrosine ammonia
lyase and other genes involved in the tyrosine biosynthesis pathway.
Conclusions: To produce coumarin derivatives (umbelliferone, scopoletin, and esculetin) in E. coli, several
constructs containing F6′H and 4CL were made, and their ability to synthesize coumarin derivatives was tested.
The solubility of F6′H was critical for the final yield. After optimization, 82.9 mg/L of umbelliferone, 79.5 mg/L of
scopoletin, and 52.3 mg/L of esculetin were biosynthesized from the corresponding HCs, respectively in E. coli.
Umbelliferone and esculetin were also synthesized from glucose using engineered E. coli strains. The final yields
of umbelliferone and esculetin were 66.1 and 61.4 mg/L, respectively.
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Plants synthesize many types of phenolic compounds.
Depending on their carbon skeletons, these phenolic
compounds can be divided into four groups [1]. The first
group is based on phenolic acids, whose carbon skeleton
is C6-C1, and includes gallic acid, salicylic acid, and ben-
zoic acid. The second group is hydroxycinnamic acids
(HCs, C6-C3), which include p-coumaric acid, caffeic
acid, and coumarin. The third group, the stilbenes, has a
C6-C2-C6 skeleton, and includes resveratrol, piceatannol,
and pallidol. The last group includes the flavonoids,
which have a C6-C3-C6 skeleton, and includes quer-
cetin, genistein, and apigenin. These plant phenolics
are all synthesized from cinnamic acid derived from* Correspondence: jhahn@konkuk.ac.kr
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unless otherwise stated.phenylalanine through the action of phenylalanine
ammonia lyase (PAL). Malonyl-CoA supplies carbon
to cinnamonyl-CoA to make the stilbenes and the
flavonoids [2], while β-oxidation of cinnamic acid
leads to the formation of phenolic acids [3].
Coumarins contain a backbone of 1,2-benzopyrone
and are classified into four groups; simple coumarins, fu-
ranocoumarins, pyranocoumarins, and prenylated couma-
rins. Simple coumarins include scopoletin, umbelliferone,
esculetin, and others [4]. Coumarins are plant secondary
metabolites that are produced as either defensive com-
pounds against pathogens [5,6] or iron chelators in the
soil [7]. Biological activities of coumarins and their
derivatives include antibacterial, antiviral, antifungal,
anti-inflammatory, anticancer, anticoagulant, and anti-
hypertensive activities [8]. As more impacts of coumarins
on human have emerged, natural coumarins are serving ashis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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useful coumarin derivatives [8,9].
The biosynthetic pathway from cinnamic acid to cou-
marin was first elucidated in Arabidopsis thaliana [10].
The hydroxylation at the 6′-carbon of cinnamoyl-CoA
by a 2-oxoglutarate-dependent dioxygenase (feruloyl
CoA 6′-hydroxylase [F6′H], also known as p-coumaryol
CoA 2′-hydroxylase [C2′H]) is a key step for the biosyn-
thesis of coumarin [11]. In sweet potato (Ipomoea batatas),
genes homologous to F6′H from A. thaliana (IbF6′H1 and
IbF6′H2) have been cloned and characterized [12]. These
studies opened possibilities that three coumarins (umbelli-
ferone, esculetin, and scopoletin) are synthesized from
p-coumaric acid, caffeic acid, and ferulic acid, respect-
ively, by a combination of p-cinnamic acid:CoA ligase
(4CL) and F6′H [10,12] (Figure 1).
Model microorganisms have been used to synthesize
plant phenolic compounds. Hydroxycinnamic acid, fla-
vonoid, and stilbene have successfully been synthesized
in Escherichia coli [13-15]. Coumarin can be synthe-
sized from either phenylalanine or tyrosine using threeFigure 1 Biosynthesis pathway of coumarins starting with glucose. ppsA, p
DNA-binding transcription repressor; aroG, deoxyphosphoheptonate aldola
tyrB, phenylalanine aminotransferase; TAL, tyrosine amino lyase; 4CL, 4-coum
O-methyltransferase; F6′H, feruloyl CoA 6′-hydroxylase. Tyrosine inhibits tyrRenzymes, phenylalanine (or tyrosine) ammonia lyase (PAL
or TAL), 4-cinnamic acid:coenzyme A ligase (4CL), and
F6′H. Phenylalanine and tyrosine can be converted into
cinnamic acid and p-coumaric acid by PAL and TAL,
respectively [16,17]. Caffeic acid is synthesized from
p-coumaric acid by hydroxylation using 4-hydroxyphe-
nylacetate 3-hydroxylase (HpaBC) from E. coli [18] or
a monooxygenase called Sam5 from Saccharothrix
espanaensis [19]. Subsequent O-methylation of caffeic
acid produces ferulic acid [20]. Attachment of coen-
zyme A to each HC and the spontaneous cyclization
of 6′-hydroxycinnamoyl-CoAs in E. coli result in the
formation of coumarins. Simple coumarins and their
derivatives have been synthesized from either hydroxy-
cinnamic acid or glucose [21-23]. This study used F6′
H from A. thaliana and I. batatas and 4CL from A.
thaliana to produce umbelliferone and scopoletin
from p-coumaric acid and ferulic acid, respectively, In
addition, by employing TAL, HapBC, and CCoAOMT
(caffeoyl CoA O-methyltransferase) along with F6′H
and 4CL, Lin et al. [21] also synthesized umbelliferonehosphoenolpyruvate synthetase; tktA, transketolase; tyrR, phenylalanine
se; tyrA, prephenate dehydrogenase; pheA, prephenate dehydratase;
aroyl-CoA ligase; C3H, coumarate 3-hydroxylase; COMT, caffeic acid
, and tyrA.
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thesized by this method was low. The bottleneck for
the synthesis of coumarin is probably the conversion
of hydroxycinnamoyl-CoA to 6′-hydroxy cinnamoyl-CoA.
In this paper, we overcome this block by increasing the
solubility of F6′H, thereby increasing the yield of couma-
rin. We report here the biosynthesis of coumarins from
both hydroxycinnamic acids and glucose.Table 1 Plasmids and strains used in the present study
Plasmids or E. coli
strain
Relevant properties or genetic marker
Plasmids
pACYCDuet P15A ori, Cmr
pCDFDuet CloDE13 ori, Strr
pETDuet f1 ori, Ampr
pGEX 5X-3 pBR322ori, Ampr
pA-SeTAL pACYCDuet carrying TAL from Saccharothrix
pA-aorG-SeTAL-tyrA pACYCDuet carrying TAL from S. espanaensis
pA-aorGfbr-SeTAL-tyrAfbr pACYCDuet carrying TAL from S. espanaensis
pA-aroGfbr-ppsA-tktA-SeTAL-
tyrAfbr
pACYCDuet carrying TAL from S. espanaensis
pE-pIbF6′H2-pOs4CL pETDuet harboring F6′H2 from Ipomoea bata
controlled by independent T7 promoter.
pE-pIbF6′H2-Os4CL pETDuet harboring F6′H2 from Ipomoea bata
controlled by one T7 promoter.
pG-pIbF6′H2-pOs4CL pGEX 5X-3 harboring F6′H2 from Ipomoea bata
glutathione S-transferase. F6′H2 is controlled by
pG-pIbF6′H2-Os4CL pGEX 5X-3 harboring F6′H2 from Ipomoea bata
with glutathione S-transferase. Each gene is con
pG-pIbF6′H1-Os4CL pGEX 5X-3 harboring F6′H1 from Ipomoea bata
glutathione S-transferase. Each gene is controlle
BL21 (DE3) F- ompT hsdSB(rB
- mB





B-CM1 BL21 harboring pE-pIbF6′H2-Os4CL
B-CM2 BL21 harboring pE-pIbF6′H2-pOs4CL
B-CM3 BL21 harboring pG-pIbF6′H2-pOs4CL
B-CM4 BL21 harboring pG-pIbF6′H2-Os4CL
B-CM5 BL21 harboring pE-pIbF6′H1-Os4CL
B-CM6 BL21 harboring pG-pIbF6′H2-Os4CL and pA-
B-CM7 BL21 harboring pG-pIbF6′H2-Os4CL and pA-
B-CM8 BL21 harboring pG-pIbF6′H2-Os4CL and pA-
B-CM9 BL21 harboring pG-pIbF6′H2-Os4CL and pA-
B-CM10 BydiI harboring pG-pIbF6′H2-Os4CL and pA-
B-CM11 BybgC harboring pG-pIbF6′H2-Os4CL and pA
B-CM12 BybgC harboring pG-pIbF6′H1-Os4CL, pA-aroResults
Production of coumarin from hydroxycinnamic acid in
E. coli
Coumarin is synthesized from hydroxycinnamic acid by
the products of two genes, 4CL and F6′H. Genes from
Oryza sativa (Os4CL) and I. batatas (IbF6′H2) were
cloned and transformed into E. coli. The E. coli transfor-






espanaensis Kim et al. (2013) [26]
, aroG and tyrA from E. coli Kim et al. (2013) [26]
, aroGfbr, and tyrAfbr from E. coli This study
, aroGfbr, PPSA, tktA, and tyrAfbr from E. coli Kim et al. (2013) [26]
tas and 4CL from Oryza sativa. Each gene is This study
tas and 4CL from Oryza sativa. Each gene is This study
tas and 4CL from Oryza sativa. F6′H2 was fused with
pTac promoter and 4CL is controlled by T7 promoter.
This study
tas and 4CL from Oryza sativa. F6′H2 was fused
trolled by one pTac promoter.
This study
tas and 4CL from Oryza sativa. F6′H2 was fused with
d by one pTac promoter.
This study
Novagen
Kim et al. (2013) [26]













Gfbr-SeTAL-tyrAfbr, and pC-Sam5 This study
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liquid chromatography (HPLC). As shown in Figure 2C,
the culture filtrate from B-CM1 showed a new peak that
had the same retention time as a standard of scopoletin.
The molecular mass of the reaction product was 192-Da
(g/mol) (Figure 2D), which corresponds to the predicted
molecular mass of scopoletin. B-CM1 produced 3.5
mg/L scopoletin.
F6′H is a dioxygenase. Dioxygenases are sometimes
poorly expressed in E. coli due to low solubility. There-
fore, we fused F6′Hs to glutathione S-transferase (GST)
to increase the solubility and stability. GST-fusion proteins
have been shown to exhibit increased solubility and stability
compared to His-tagged fusion proteins [24]. In addition,
we made operon-type and pseudo operon-type constructs
with 4CL and F6′H. The operon-type construct has one T7
promoter which controls the expression of both 4CL and
F6′H. On the other hand, each gene is controlled by an
independent T7 promoter in the pseudo operon-type con-
struct. Therefore, we generated four constructs and tested
them for the production of scopoletin from ferulic acid (B-
CM1 to B-CM4). In two constructs, pG-pIbF6′H2-pOs4CL
and pG-pIbF6′H2-Os4CL (Table 1), IbF6′H2 was fused
with GST. Two genes, IbF6′H2 and Os4CL, were controlled
by either two promoters in pG-pIbF6′H2-pOs4CL and
pE-pIbF6′H2-pOs4CL (pseudo-operon type) or one
promoter in pG-pIbF6′H2-Os4CL and pE-pIbF6′H2-
Os4CL (operon type). In cases in which one promoter
controlled two genes, a ribosome binding site (RBS)
was attached in front of each gene. In addition, IbF6′H
was located before Os4CL when both genes were con-
trolled by one promoter. This orientation accumulated
a fewer reaction intermediates [25]. Each construct wasFigure 2 Production of scopoletin by feeding ferulic acid to E. coli strain B
products, P1 and P2, D: Mass spectrum of reaction product P1.transformed into E. coli BL21 (DE3) and the resulting
strains were tested for the ability to produce scopoletin.
The strains harboring IbF6′H2 fused with GST showed
more scopoletin production than strains harboring
IbF6′H2 alone. B-CM3 and B-CM4, both of which
contained the GST-IbF6′H2 fusion protein, produced
approximately 34.6 and 59.7 mg/L of scopoletin, re-
spectively, whereas B-CM1 and B-CM2 produced 3.5
and 8.1 mg/L, respectively (Figure 3). This indicates
that the GST-fusion resulted in a higher yield of sco-
poletin, presumably due to increased solubilization
and stability of IbF6′H2. Therefore, we decided to use
the operon-type construct fused with GST (pG-pIbF6′
H2-Os4CL).
Using strain B-CM4, the effect of the medium on the
production of scopoletin was examined. After protein
induction, cells were resuspended in LB, M9, or YM9
(M9 containing 1% yeast extract), and incubated with
ferulic acid. Cells grown in LB accumulated more sco-
poletin than the other media (59.2 mg/L scopoletin vs.
13.1 mg/L in YM9 and 4.3 mg/L in M9).
We also generated a GST-IbF6′H1 fusion gene, which
was subcloned with Os4CL in an operon-type configur-
ation (pG-pIbF6′H1-Os4CL). E. coli strains B-CM4, which
contains pG-pIbF6′H2-Os4CL, and B-CM5, which con-
tains pG-pIbF6′H1-Os4CL, were tested for production of
umbelliferone, esculetin, and scopoletin from p-coumaric
acid, caffeic acid, and ferulic acid, respectively. The two
F6′Hs are expected to exhibit different substrate specifi-
city. All E. coli strains converted p-coumaric acid, caffeic
acid, and ferulic acid into umbelliferone, esculetin, and
scopoletin, respectively. The structures of the products
were confirmed using nuclear magnetic resonance (NMR)-CM1, A: ferulic acid standard (F), B: scopoletin standard (S), C: reaction
Figure 3 Comparison of different constructs for the production of
scopoletin. B-CM1: BL21 harboring pE-pIbF6′H2-Os4CL, B-CM2: BL21
harboring pE-pIbF6′H2-pOs4CL, B-CM3: BL21 harboring pG-pIbF6′H2-
pOs4CL, B-CM4: BL21 harboring pG-pIbF6′H2-Os4CL.
Figure 4 Substrate preference of F6′H1 and F6′H2 Strain B-CM4 contains
F6′H2 while B-CM5 contains F6′H1.
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yield was different depending on the E. coli strain used
and the substrate. B-CM4 produced about 38.2 mg/L
umbelliferone, but B-CM5 produced 29.0 mg/L. Scopole-
tin was also produced at a higher amount in B-CM4 (ap-
proximately 59.4 mg/L) than in B-CM5 (33.6 mg/L). On
the other hand, more esculetin was produced in B-CM5
(approximately 25.2 mg/L) than in B-CM4 (16.0 mg/L)
(Figure 4). IbF6′H2 was superior for the production of
umbelliferone and scopoletin, while IbF6′H1 was superior
for the production of esculetin.Optimization of umbelliferone, scopoletin, and esculetin
production
The optimal initial concentration of substrates (p-cou-
maric acid, caffeic acid, and ferulic acid) was examined
for the production of umbelliferone, scopoletin, and
esculetin, respectively. B-CM4 was used for the produc-
tion of umbelliferone and scopoletin while B-CM5 was
used for the production of esculetin. Approximately 90%
of the p-coumaric acid was converted to umbelliferone
at 0.3, 0.4, 0.5 mM p-coumaric acid. The production of
umbelliferone continued to increase until 0.7 mM p-
coumaric acid, after which the yield was not further
increased very much, and p-coumaric acid accumulated.Therefore, 0.7 mM of p-coumaric acid was selected as
the initial substrate concentration. Next, we determined
the optimal cell density at 0.7 mM p-coumaric acid.
Production of umbelliferone continued to increase until
OD600 = 5, after which the yield decreased. B-CM4 at
a cell density at OD600 = 5, produced approximately
0.51 mM (82.9 mg/L) of umbelliferone from 0.7 mM
(114.9 mg/L) p-coumaric acid for a conversion yield
of approximately 73%.
Using the same approach, the optimal initial substrate
concentration and cell density were determined for both
the production of scopoletin from ferulic acid and the
production of esculetin from caffeic acid. The optimal
substrate concentration and cell density for both scopoletin
and esculetin were 0.7 mM at OD600 = 5, respectively. Under
these conditions, approximately 79.5 mg/L of scopoletin
(0.41 mM; 59% conversion) and 52.3 mg/L (0.29 mM; 41%
conversion) of esculetin were produced after a 12 h reaction.
Synthesis of umbelliferone and esculetin from glucose
Umbelliferone and esculetin are synthesized from p-cou-
maric acid, and caffeic acid, respectively. p-Coumaric
acid is synthesized from tyrosine by the action of tyrosine
ammonia lyase (TAL). Subsequently, 3′-hydroxylation of
p-coumaric acid leads to the synthesis of caffeic acid.
Therefore, for the synthesis of umbelliferone, an additional
gene, TAL is needed, which was previously cloned in our
lab [26]. E. coli BL21 (DE3) was transformed with the
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ing strain, B-CM6, was used to synthesize umbellifer-
one. The analysis of the culture filtrate by HPLC showed
a peak (peak 3 in Figure 5B) that has the same retention
time as standard umbelliferone. The molecular mass of
this reaction product was 162 Da (g/mol), which is the
predicted molecular mass of umbelliferone (data not
shown). Therefore, umbelliferone was successfully syn-
thesized by strain B-CM6.
p-Coumaric acid is synthesized from tyrosine. There-
fore, the intracellular tyrosine concentration is likely
to have an effect on the yield of umbelliferone. In order
to increase tyrosine production in E. coli, different com-
binations of four genes (aroG, tyrA, ppsA, and tktA)
were used. These four genes have been used previously
[26]. B-CM7, in which aroG and tyrA were overex-
pressed, produced more umbelliferone than other strains
(23 mg/L) (Figure 6). The strains B-CM8 and B-CM9, in
which feedback-free aroG (aroGfbr) and tyrA (tyrAfbr)
[27] were overexpressed, produced less umbelliferone
than the strain B-CM6, in which neither aroG nor
tyrA was overexpressed. Although it is known that the
feedback-free version of aroG and tyrA increase the pro-
duction of tyrosine [28], this result indicates that there
might be a certain optimal concentration of tyrosine
beyond which umbelliferone yield does not increase, and
even decrease probably due to the metabolic load of pro-
ducing too much tyrosine.
During the synthesis of umbelliferone, two thioester
intermediates (p-coumaroyl-CoA and 6′-hydroxy p-cou-
maroyl-CoA) are synthesized. These two intermediates
might be degraded by thioesterase(s). To prevent theFigure 5 Production of umbelliferone from glucose using B-CM6. A, stand
p-coumaric acid; P2, p-coumaric acid; P3, umbelliferone).degradation of the two thioester intermediates and thereby
increase the final yield of umbelliferone, two thioesterase
mutants (BydiI and BybgC in Table 1) were made, and the
ability of each mutant to produce umbelliferone was
tested. ydiI has esterase activity toward 1,4-dihydroxy-2-
naphthoyl-coenzyme A [29]. YbgC was predicted to en-
code acyl-CoA thioesterase. B-CM10 (Table 1) derived
from BydiI, produced 17.2 mg/L umbelliferone, which
was less than B-CM7 derived from E. coli BL21 (DE3)
(23.2 mg/L). On the other hand, B-CM11 derived from
BybgC synthesized approximately 32.1 mg/L umbelli-
ferone (Figure 6), indicating that ybgC may hydrolyze
the thioester bond in p-coumaroyl-CoA and/or 2-
hydroxy p-coumaroyl-CoA. Therefore, we decided to
use the strain BybgC to produce umbelliferone.
Strain B-CM11 was used to produce umbelliferone
from glucose. First, the optimal B-CM11 cell density for
umbelliferone production was examined. Cell density
was adjusted from OD600 = 0.5 to 3.0. The yield of umbel-
liferone increased from 32.2 mg/L at OD600 = 0.5 to
67.2 mg/L at OD600 = 2.5, but at OD600 = 3.0, it decreased
to 48.4 mg/L. Therefore, a cell density of OD600 = 2.5 was
used as the cell density for umbelliferone production.
Next, the incubation temperature of B-CM11 was exam-
ined. B-CM11 was grown at 20, 25, 30, and 37°C. The
highest production of umbelliferone occurred in cells
grown at 25°C (68.2 mg/L). At a lower or higher
temperature, umbelliferone production dramatically de-
creased. The yields at 20°C and 30°C were approximately
36.3 mg/L and 22.5 mg/L, respectively. Umbelliferone at
37°C was one-tenth the productivity at 30°C. The different
yields at different temperatures may relate to the growthard umbelliferone; B, reaction product from B-CM6 (P1, 2-hydroxy
Figure 6 Analysis of reaction product from B-CM12. A, standard esculetin; B, reaction product from B-CM12 (P1, esculetin; P2, caffeic acid; P3,
p-coumaric acid; P4, umbelliferone).
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Low temperature lowers the rate of cell growth, while high
temperature can influence the expression of the intro-
duced genes. Therefore, the optimal temperature is the
one that does not hinder cell growth and maximizes
expression of the introduced gene.
Using strain B-CM11, umbelliferone production was
monitored for 48 h. Initial cell concentration was
OD600 = 2.5, and the cells were grown at 25°C. Umbel-
liferone was synthesized rapidly from 6 to 18 h, after
which production was not increased dramatically. The
production reached a maximum at 36 h. The final
yield was 66.1 mg/L (Figure 7A), which was less than
that obtained by feeding p-coumaric acid (82.9 mg/L).
Although B-CM11 continued to synthesize p-coumaric
acid, most of it was converted into umbelliferone. This
indicated that the overall metabolic flow from the
production of p-coumaric acid to the production of
umbelliferone is well-balanced.
Esculetin was also synthesized from glucose by adding
one additional gene (Sam5) that encodes a protein to con-
vert p-coumaric acid into caffeic acid. We also tested the
four constructs (pA-SeTAL, pA-aroG-SeTAL-tyrA, pA-
aroGfbr-SeTAL-tyrAfbr, and pA-aroGfbr-ppsA-tktA-SeTAL-
tyrAfbr) for the production of esculetin. The strain harbor-
ing pA-aorGfbr-SeTAL-tyrAfbr produced more esculetin
than other strains harboring different constructs (data not
shown). Therefore, B-CM12 was used for the production
of esculetin. The product was confirmed based on HPLC
retention time and the MS/MS fragmentation pattern
(Figure 8 and data not shown). The optimal cell con-
centration was determined to be OD600 = 1.5, and theoptimal incubation temperature was 25°C. Using the
optimized conditions, production of esculetin was
monitored. Esculetin production needs more time than
umbelliferone because of an additional step for the
conversion of p-coumaric acid into caffeic acid. Escule-
tin production continued to increase until 60 h, at
which point approximately 61.4 mg/L esculetin was
synthesized (Figure 7B), similar to the amount which
was obtained from feeding caffeic acid. At 60 h, the
production of esculetin was maximum and caffeic acid
began to accumulate.
Discussion
Three coumarins, umbelliferone, esculetin, and scopole-
tin were synthesized by feeding the corresponding
hydroxycinnamic acids to E. coli harboring 4CL and F6′
H. The yields ranged from 52.3 mg/L for esculetin,
79.5 mg/L for scopoletin, and 82.9 mg/L for umbellifer-
one. The final yields of these three coumarins were
much higher than previous reported, 4.3 and 27. 8 mg/L
for umbelliferone and scopoletin, respectively [21], al-
though the catalytic efficiency of the F6′H used in the
previous study was better than that used in the current
study [10,12]. There are several possible explanations
for the difference in the final yields. First, the tagged
system of F6′H seems to be critical. The soluble form of
F6′H was critical for the final yield. The GST-fusion of
F6′H is more soluble form of F6′H. In addition, conver-
sion of each HC into the corresponding HC-CoA seems
to be an important point, because the 4CL, used in the
two studies were different. Second, expression of 4CL
and F6′H was affected by the number of promoters.
Figure 7 Effect of constructs (A) and E. coli mutant (B) on the production of umbelliferone from glucose.
Figure 8 Production of umbelliferone (A) and esculetin (B) using B-CM11 and B-CM12 from glucose, respectively.
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which expression of the two genes was controlled by
two independent T7 promoter, gave less scopoletin
than the operon-type, in which the expression of both
genes was controlled by one T7 promoter. It was also
shown that E. coli harboring the operon-type con-
struct of 4CL and CHS (chalcone synthase) synthe-
sized more pinocembrin than E. coli harboring the
pseudo-operon type [30]. The order of genes in the
construct seemed to be important. Lin et al. [21] used
the operon-type construct with 4CL and F6′H. How-
ever, F6′H was place in front of 4CL in their con-
struct, which is opposite of ours. Although it was
possible that the use of different 4CL genes in the
two studies could have contributed to the difference
in the final yield, the order of genes in the construct
could be another factor that influenced the final yield.
The gene that acts at the later stage of a metabolic
pathway should be placed in front of the gene that
acts at the earlier stage in order to accumulate less
intermediate. It was observed that the gene order in
the construct influences the final yield of the product
[25,30].
Umbelliferone and esculetin were also synthesized from
glucose. It was surprising that the final yield from glucose
was comparable to that from the feeding study. It is gener-
ally known that final yield is decreased when more genes are
added to E. coli. The use of an E. coli ybgC deletion mutant
might prevent the degradation of HC-CoA, which is the
substrate of F6′H. The use of E. coli ybgC deletion mutant
resulted in higher production of esculetin and umbelliferone
from glucose. However, deleting ybgC did not have any
effect on the production of esculetin and umbelliferone
when caffeic acid and p-coumaric acid were fed to E. coli. It
seems that the conversion of caffeoyl-CoA or p-coumaroyl-
CoA into esculetin or umbelliferone is a bottle neck for the
overall reaction. When either caffeic acid or p-coumaric acid
was fed to E. coli, the corresponding CoA derivatives were
formed by 4CL, which is faster than conversion of them into
esculetin or umbelliferone by F6′H, and the amount of
caffeoyl-CoA or p-coumaroyl-CoA was dependent only on
the amount of caffeic acid or p-coumaric acid, respectively.
Therefore, although some caffeoyl-CoA or p-coumaroyl-
CoA is degraded by ybgC, caffeoyl-CoA or p-coumaroyl-
CoA are still available for the next reaction catalyzed by F6′
H. On the other hand, when caffeic acid or p-coumaric acid
are synthesized from tyrosine and then converted into the
corresponding CoAs, most of the caffeoyl-CoA or p-cou-
maroyl-CoA was degraded by ybgC and the remaining
amounts of them were not enough for the capability of F6′
H, and this therefore resulted in decreasing the production
of esculetin or umbelliferone. Therefore, deletion of ybgC
in E. coli prevents degradation of caffeoyl-CoA or p-coumar-
oyl-CoA and increases the final yields. We cannot excludethe possibility that ybgC degrades 6′-hydroxy caffeoyl-CoA
or 6′-hydroxy p-coumaroyl-CoA.
Conclusions
Coumarins are plant secondary metabolites that contain
a backbone of 1,2-benzopyrone. Natural coumarins serve
as a backbone for the synthesis of more active deriva-
tives. We used E. coli to synthesize coumarins. E. coli
strains harboring the optimized construct of F6′H and
4CL were used to synthesize umbelliferone, esculetin,
and scopoletin from p-coumaric acid, caffeic acid, and
ferulic acid, respectively. Umbelliferone (82. 9 mg/L),
scopoletin (79.5 mg/L), and esculetin (52.3 mg/L) were
synthesized after the optimization of cell concentration and
the initial substrate feeding concentration. In addition,
umbelliferone, and esculetin were synthesized from glucose.
A ybgC deletion mutant (BydgC), which was assumed to
prevent the degradation of either hydroxycinnamoyl-CoA
or 6′-hydroxy hydroxycinnamoyl-CoA was used and this
strain was transformed with TAL and other genes involved
in the tyrosine biosynthesis pathway. Using these strategies,




4CL (4-coumarate: CoA ligase) from Oryza sativa was
cloned previously [31]. p-Coumaroyl Coenzyme A/feru-
loyl Coenzyme A ortho-hydroxylases from sweet potato
(Ipomoea batatas: IbF6′H1 [GenBank ID: AB636153] and
IbF6′H2 [GenBank ID: AB636154]) were cloned using re-
verse transcription-polymerase chain reaction (RT-PCR).
Total RNA from sweet potato tuber tissue was isolated
using Plant Total RNA Isolation Kit (Qiagen, Hilden,
Germany), and cDNA was synthesized with Omniscript
reverse transcript (Qiagen). The forward primers of IbF6′
H1 and IbF6′H2 were 5′-ATGGCTCCAACACTCTT
GAC-3′ and 5′-ATGAATCAAACACTCGCTGC-3′, re-
spectively. The reverse primers were 5′-TCAGATCTT
GGCGTAATCGA-3′ and 5′-TCAAATGTTGGCAAAAT
CGA-3′. The resulting PCR product of each gene was
subcloned into pGEM-T easy vector (Promega, Madison,
USA) and sequenced. Each gene was then reamplified
with the forward primer containing an EcoRI site, and the
reverse primers containing a NotI site. The PCR product
was subcloned into the EcoRI/NotI sites of pET-Duet
(Novagen). Os4CL, which was cloned previously [31],
was amplified using PCR with 5′-ATCATATGGG
GTCGGTGGCGGCGGAGGAGG-3′ and 5′-ATCTCG
AGTTAGCTGCTTTTGGGCGCATC-3′ (NdeI site and
XhoI site are indicated as italic), and subcloned into the
NdeI/XhoI sites of pET-Duet1 containing IbF6′H1 or
IbF6′H2. Each gene in these constructs was controlled by
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pE-pIbF6′H1-pOs4CL or pE-pIbF6′H2-pOs4CL (Table 1).
To make a construct in which both genes were controlled
by one promoter (operon-type), Os4CL was amplified
with a forward primer containing a ribosomal binding site
(RBS) and a NotI site (5′-ATGCGGCCGCaaggagatata
ccaATGGGGTCGGTGGCG-3′; NotI site is indicated as
italic and RBS is shown in lower case), and the reverse
primer containing a XhoI site (5′-ATCTCGAGTTAG
CTGCTTTTGGGCGCATC-3′; XhoI site is indicated as
italic). The resulting PCR product was subcloned into the
NotI/XhoI sites of pET-Duet1 containing IbF6′H1 or
IbF6′H2. The resulting constructs, pE-pIbF6′H1-Os4CL
and pE-pIbF6′H2-Os4CL contained a single promoter
but an RBS site in front of each gene. pE-pIbF6′H1-
Os4CL, and pE-pIbF6′H2-Os4CL were digested with
EcoRI and XhoI, and the fragment containing IbF6′H1
and Os4CL or IbF6′H2 and Os4CL was subcloned into
the EcoRI/XhoI sites of pGEX 5X-3 (GE Healthcare,
USA). The resulting constructs were named pG-pIbF6′
H1-Os4CL, and pG-pIbF6′H2-Os4CL, respectively. To
make the construct with two promoters and F6′H fused
with GST, PCR was carried out using pE-pIbF6′H1-
Os4CL, or pE-pIbF6′H2-Os4CL as a template using Pfu
DNA polymerase with the primers, 5′-ATGAATTCG
ATGCCTTCAACAACACTCTCC-3′ for IbF6′H1 (EcoRI
site is indicated as italic) or 5′-ATGAATTCGATGAT
GCCTTCAACAACACTC-3′ for IbF6′H2 (EcoRI site
indicated as italic) and 5′-TTAGCTGCTTTTGGGC
GCATC-3′ for Os4CL. The resulting PCR product was
digested with EcoRI and subcloned into the EcoRI/
SmaI sites of pGEX 5X-3. The resulting constructs
were pG-pIbF6′H1-pOs4CL and pG-pIbF6′H2-pOs4CL,
respectively.
The TAL gene from Saccharothrix espanaensis (SeTAL),
aroG, tyrA, and the feedback-free versions of aroG
(aroGfbr) and tyrA (tyrAfbr) were cloned previously [26].
For the pA-aroGfbr-SeTAL-tyrAfbr construct, aroGfbr and
tyrAfbr were introduced into the EcoRI/SalI and the NdeI/
KpnI sites of pACYCDuet, respectively, and was named
pA-aroGfbr-tyrAfbr. The SeTAL gene was cloned into the
EcoRI/NotI sites of pACYDUet and named pA-SeTAL.
SeTAL containing the T7 promoter and RBS was ampli-
fied with two primers flanking XhoI and NotI using
pA-SeTAL as a template. The PCR product was digested
with XhoI/NotI and ligated into the corresponding sites of
pA-aroGfbr-tyrAfbr. The resulting construct was named
pA-aroGfbr-SeTAL-tyrAfbr. pA-aroG-SeTAL-tyrA was con-
structed using the same method described above.
Production of coumarins in E. coli
E. coli transformants containing pG-IbF6′H1-Os4CL or pG-
IbF6′H2-Os4CL were grown in LB containing 50 μg/mL
ampicillin for 16 h at 37°C. This culture was inoculated intofresh LB containing 50 μg/mL ampicillin and grown to an
OD600 = 0.8. Isopropyl β-D-1-thiogalactopyranoside (IPTG)
was added at a final concentration of 1 mM and the culture
was grown for another 6 h at 25°C. Cells were harvested,
and the cell concentration was adjusted to OD600 = 3 with
10 mL of fresh LB containing 50 μg/mL ampicillin in
100 mL flask. The substrate (p-coumaric acid, caffeic acid, or
ferulic acid) was added at a concentration of 400 μM. The
resulting culture was incubated at 30°C for 12 h with shak-
ing. The effect of medium on the production of scopoletin
was examined using LB, M9 (containing 2% glucose), or
YM9 (M9 containing 2% glucose and 0.2% yeast extract).
We used 10 mL of each medium in 100 mL flask.
To determine the substrate concentration to produce
the highest yield of coumarin derivatives, substrate was
added at 0.3, 0.4, 0.5, 0.7, 0.9, 1.2, or 1.5 mM. The cell
density was OD600 = 3. The mixture was incubated at 30°
C for 12 h with shaking at 180 rpm. For the optimal cell
density, cell density was adjusted to OD600 = 1, 2, 3, 5, or
10. Substrate was added at 0.7 mM, and the mixture was
incubated at 30°C for 12 h with shaking at 180 rpm. The
reaction scale was used as described above.
The culture (200 μL) was extracted twice with the equal
volume of ethylacetate. The organic phase was recovered
and evaporated to dryness. The remaining residue was
dissolved in 60 μL of dimethylsulfoxide (DMSO) and ana-
lyzed using a Thermo Ultimate 3000 HPLC equipped with
a photo diode array (PDA) detector and a Varian C18
reversed-phase column (Varian, 4.60 × 250 mm, 3.5 μm
particle size) by injecting 10 μL. The mobile phases con-
sisted of 0.1% formic acid in water or acetonitrile. The
program was: 15% acetonitrile at 0 min, 35% acetonitrile
at 10 min, 90% acetonitrile at 12 min, 90% acetonitrile at
15 min, 15% acetonitrile at 15.1 min, and 15% acetonitrile
at 20 min. The flow rate was 1 mL/min, and the separ-
ation was monitored at 290, 310, and 340 nm.
Umbelliferone, scopoletin, and esculetin were pur-
chased from Sigma (St. Louis, MO, USA) and used as
standards to calculate yields of umbelliferone, scopole-
tin, or esculetin. The means and standard errors were
calculated from triplicate experiments. Analysis of
variance (ANOVA) was carried out using Tukey’s method
with a significance level of P = 0.01 using 2010 Microsoft
Office Excel.
Mass spectrometry (MS) was performed as described
previously [31]. Structures of products were determined
using nuclear magnetic resonance spectroscopy (NMR)
[32]. The NMR data were as follows; Umbelliferone: 1H
NMR (400 MHz, Acetone-d6) δ 7.87 (d, J = 9.5 Hz, 1H),
7.52 (d, J = 8.4 Hz, 1H), 6.85 (dd, J = 8.5, 2.1 Hz, 1H),
6.75 (d, J = 1.9 Hz, 1H), 6.17 (d, J = 9.5 Hz, 1H).
Scopoletin: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J =
9.4 Hz, 1H), 6.90 (s, 1H), 6.84 (s, 1H), 6.52 (d, J = 9.5 Hz,
1H), 3.88 (s, 3H).
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(d, J = 9.6 Hz, 1H), 7.05 (s, 1H), 6.79 (s, 1H), 6.15 (d, J =
9.6 Hz, 1H).Synthesis of umbelliferone and esculetin from glucose
An overnight culture of each strain was inoculated into
fresh LB medium containing 50 μg/mL of ampicillin,
and chloramphenicol and the cells were grown at 37°C
with shaking at 180 rpm until the OD600 exceeded 1.0.
The cells were collected by centrifugation. The cell
density was adjusted to an OD600 of 1.0 with 10 mL of
M9 medium supplemented with 1% yeast extract, 2%
glucose, 50 μg/mL of ampicillin and chloramphenicol
and 1 mM IPTG in 100 mL flask and then incubated at
30°C for 48 h with shaking. The reaction product was
analyzed by HPLC.
To determine the optimal cell concentration for the
production of umbelliferone, B-CM11 cells were grown
and protein expression was induced as described above.
Cells were harvested by centrifugation and cell concen-
trations were adjusted to OD600 = 0.5, 1. 1.5, 2.0, 2.5, or
3.0 with M9 medium containing 2% glucose, 1% yeast
extract, 50 μg/mL chloramphenicol and ampicillin, and
1 mM IPTG. Each strain was grown at 30°C for 48 h
and production of umbelliferone determined by HPLC.
To determine the optimum incubation temperature, the
cell concentration of B-CM11 was adjusted to OD600 = 2.5,
and cells were then incubated at 20, 25, 30, and 37°C for
48 h with shaking at 180 rpm. The yield of umbelliferone
from each culture was determined by HPLC. Esculetin pro-
duction from glucose using B-CM12 was carried out using
similar methods to that of umbelliferone production.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JHA initiated and coordinated the project. SMY, GYS, BGK, and JHA
performed experiments, and analyzed data. SMY, BGK, and JHA wrote the
paper. All authors approved the final manuscript.
Acknowledgements
This work was supported by a grant from the Next-Generation BioGreen 21
Program (PJ00948301), Rural Development Administration, and Priority Research
Centers Program through the National Research Foundation of Korea funded
by the Ministry of Education, Science and Technology (2009–0093824). We
thank Professor Jonathan Walton, Michigan State University, for editing the
manuscript.
Author details
1Department of Bioscience and Biotechnology, Bio/Molecular Informatics
Center, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701,
Korea. 2Department of Forest Resources, Gyeongnam National University of
Science and Technology, 33 Dongjin-ro, Jinju-si, Gyeongsangman-do, Jinju
660-758, Korea.
Received: 17 March 2015 Accepted: 20 April 2015References
1. Jaganath IB, Crozier A. Dietary flavonoids and phenolic compounds. In:
Fraga CG), editor. Plant Phenolics and Human Health: Biochemistry, Nutrition,
and Pharmacology. Hoboken, New Jersey: John Wiley & Sons; 2010. p. 1–49.
2. Winkel-Shirley B. Flavonoid biosynthesis. a colorful model for genetics,
biochemistry, cell biology, and biotechnology. Plant Physiol. 2001;126(2):485–93.
3. Qualley AV, Widhalm JR, Adebesin F, Kish CM, Dudareva N. Completion of
the core β-oxidation pathway of benzoic acid biosynthesis in plants. Proc
Natl Acad Sci U S A. 2012;109(40):16383–8.
4. Bourgaud F, Hehn A, Larbat R, Doerper S, Gontier E, Kellner S, et al.
Biosynthesis of coumarins in plants: a major pathway still to be unravelled
for cytochrome P450 enzymes. Phytochem Rev. 2006;5(2–3):293–308.
5. Chong J, Baltz R, Schmitt C, Beffa R, Fritig B, Saindrenan P. Downregulation of a
pathogen-responsive tobacco UDP-Glc:phenylpropanoid glucosyltransferase
reduces scopoletin glucoside accumulation, enhances oxidative stress, and
weakens virus resistance. Plant Cell. 2002;14(5):1093–107.
6. Sun H, Wang L, Zhang B, Ma J, Hettenhausen C, Cao G, et al. Scopoletin is a
phytoalexin against Alternaria alternata in wild tobacco dependent on
jasmonate signaling. J Exp Bot. 2014;65(15):4305–15.
7. Fourcroy P, Sisó-Terraza P, Sudre D, Savirón M, Reyt G, Gaymard F, et al.
Involvement of the ABCG37 transporter in secretion of scopoletin and
derivatives by Arabidopsis roots in response to iron deficiency. New Phytol.
2014;201(1):155–67.
8. Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead
compounds for their pharmacological activity. Biomed Res Int. 2013;2013:963248.
9. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and
analogues in medicinal chemistry: occurrence, synthesis and biological
activity. Curr Med Chem. 2005;12(8):887–916.
10. Kai K, Mizutani M, Kawamura N, Yamamoto R, Tamai M, Yamaguchi H, et al.
Scopoletin is biosynthesized via ortho-hydroxylation of feruloyl CoA by a
2-oxoglutarate-dependent dioxygenase in Arabidopsis thaliana. Plant J.
2008;55(6):989–99.
11. Vialart G, Hehn A, Olry A, Ito K, Krieger C, Larbat R, et al. A 2-oxoglutarate-
dependent dioxygenase from Ruta graveolens L. exhibits p-coumaroyl CoA
2′ hydroxylase activity (C2′H): a missing step in the synthesis of umbelliferone
in plants. Plant J. 2012;70(3):460–70.
12. Matsumoto S, Mizutani M, Sakata K, Shimizu B. Molecular cloning and
functional analysis of the ortho-hydroxylases of p-coumaroyl coenzyme
a/feruloyl coenzyme a involved in formation of umbelliferone and
scopoletin in sweet potato, ipomoea batatas (L.) Lam. Phytochemistry.
2012;74:49–57.
13. Malla S, Koffas MAG, Kazlauskas RJ, Kim B-G. Production of 7-O-methyl
aromadendrin, a medicinally valuable flavonoid, in Escherichia coli. Appl
Environ Microbiol. 2012;78(3):684–94.
14. Miyahisa I, Funa N, Ohnishi Y, Martens S, Moriguchi T, Horinouchi S.
Combinatorial biosynthesis of flavones and flavonols in Escherichia coli. Appl
Microbiol Biotehcnol. 2006;71(1):53–8.
15. Watts KT, Lee PC, Schmidt-Dannert C. Biosynthesis of plant-specific stilbene
polyketides in metabolically engineered Escherichia coli. BMC Biotech.
2006;6:22.
16. Cochrane FC, Davin LB, Lewis NG. The Arabidopsis phenylalanine ammonia
lyase gene family: kinetic characterization of the four PAL isoforms.
Phytochemistry. 2004;65(11):1557–64.
17. Kyndt JA, Meyer TE, Cusanovich MA, Van Beeumen JJ. Characterization of a
bacterial tyrosine ammonia lyase, a biosynthetic enzyme for the photoactive
yellow protein. FEBS Lett. 2002;512(1–3):240–4.
18. Lin Y, Yan Y. Biosynthesis of caffeic acid in Escherichia coli using its
endogenous hydroxylase complex. Microb Cell Fact. 2012;11:42.
19. Berner M, Krug D, Bihlmaier C, Vente A, Müller R, Bechthold A. Genes and
enzymes involved in caffeic acid biosynthesis in the actinomycete
Saccharothrix espanaensis. J Bacteriol. 2006;188(7):2666–73.
20. Li L, Popko JL, Zhang X-H, Osakabe K, Tsai C-J, Joshi CP, et al. A novel
multifunctional O-methyltransferase implicated in a dual methylation
pathway associated with lignin biosynthesis in loblolly pine. Proc Natl
Acad Sci U S A. 1997;94(10):5461–6.
21. Lin Y, Sun X, Yuan Q, Yan Y. Combinatorial biosynthesis of plant-specific
coumarins in bacteria. Met Eng. 2013;18:69–77.
22. Lin Y, Shen X, Yuan Q, Yan Y. Microbial biosynthesis of the anticoagulant
precursor 4-hydroxycoumarin. Nat Commun. 2013;4:2603.
23. Lin Y, Yan Y. Biotechnological production of plant-specific hydroxylated
phenylpropanoids. Biotech Bioeng. 2014;11(9):1895–9.
Yang et al. Microbial Cell Factories  (2015) 14:65 Page 12 of 1224. Terpe K. Overview of tag protein fusions: from molecular and biochemical
fundamentals to commercial systems. Appl Microbiol Biotechnol.
2003;60(5):523–33.
25. Lim CF, Fowler ZL, Hueller T, Schaffer S, Koffas MA. High-yield resveratrol
production in engineered Escherichia coli. App Environ Microbiol.
2011;77(10):3451–60.
26. Kim MJ, Kim B-G, Ahn J-H. Biosynthesis of bioactive O-methylated flavonoids
in Escherichia coli. Appl Microbiol Biotech. 2013;97(16):7195–204.
27. Lütke-Eversloh T, Stephanopoulos G. L-Tyrosine production by deregulated
strains of Escherichia coli. Appl Microbiol Biotechnol. 2007;2007(75):103–10.
28. Santos CNS, Koffas M, Stephanopoulos G. Optimization of a heterologous
pathway for the production of flavonoids from glucose. Met Eng.
2011;13(4):392–400.
29. Chen M, Ma X, Chen X, Jiang M, Song H, Guo Z. Identification of a hotdog
fold thioesterase involved in the biosynthesis of menaquinone in Escherichia
coli. J Bacteriol. 2013;195(12):2768–75.
30. Kim BG, Lee H, Ahn J-H. Biosynthesis of pinocembrin from glucose using
engineered Escherichia coli. J Microbiol Biotech. 2014;24(11):1536–41.
31. Lee Y-J, Jeon Y, Lee JS, Kim B-G, Lee CH, Ahn J-H. Enzymatic synthesis of
phenolic CoAs using 4-coumarate:coenzyme a ligase (4CL) from rice. Bull
Korean Chem Soc. 2007;28(3):365–6.
32. Yoon J-A, Kim B-G, Lee WJ, Lim Y, Chong Y, Ahn J-H. (2012) Production of a
novel quercetin glycoside through metabolic engineering of Escherichia coli.
Appl Env Microbiol. 2012;78(12):4256–62.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
